- Home
- INMB vs OPRX Comparison
INMB vs OPRX Comparison
Compare INMB & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- OPRX
- Stock Information
- Founded
- INMB 2015
- OPRX 2006
- Country
- INMB United States
- OPRX United States
- Employees
- INMB N/A
- OPRX N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- INMB Health Care
- OPRX Consumer Discretionary
- Exchange
- INMB Nasdaq
- OPRX Nasdaq
- Market Cap
- INMB 176.5M
- OPRX 154.9M
- IPO Year
- INMB 2019
- OPRX N/A
- Fundamental
- Price
- INMB $2.19
- OPRX $13.43
- Analyst Decision
- INMB Strong Buy
- OPRX Buy
- Analyst Count
- INMB 3
- OPRX 8
- Target Price
- INMB $24.33
- OPRX $10.81
- AVG Volume (30 Days)
- INMB 5.5M
- OPRX 336.3K
- Earning Date
- INMB 07-31-2025
- OPRX 08-07-2025
- Dividend Yield
- INMB N/A
- OPRX N/A
- EPS Growth
- INMB N/A
- OPRX N/A
- EPS
- INMB N/A
- OPRX N/A
- Revenue
- INMB $50,000.00
- OPRX $94,365,000.00
- Revenue This Year
- INMB $82.14
- OPRX $14.44
- Revenue Next Year
- INMB $28,750.98
- OPRX $10.63
- P/E Ratio
- INMB N/A
- OPRX N/A
- Revenue Growth
- INMB N/A
- OPRX 20.66
- 52 Week Low
- INMB $2.00
- OPRX $3.78
- 52 Week High
- INMB $11.64
- OPRX $15.71
- Technical
- Relative Strength Index (RSI)
- INMB 34.68
- OPRX 48.16
- Support Level
- INMB $5.60
- OPRX $12.20
- Resistance Level
- INMB $7.49
- OPRX $13.42
- Average True Range (ATR)
- INMB 1.21
- OPRX 0.87
- MACD
- INMB -0.18
- OPRX -0.33
- Stochastic Oscillator
- INMB 4.83
- OPRX 12.82
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.